Sandhoff disease
From Wikipedia, the free encyclopedia
| ICD-10 | E75.0 |
|---|---|
| ICD-9 | 330.1 |
| OMIM | 268800 |
| DiseasesDB | 29469 |
| MeSH | D012497 |
Sandhoff disease is a rare inherited lipid storage disorder that causes progressive destruction of nerve cells in the brain and spinal cord.
Contents |
[edit] Types
The most common and severe form of Sandhoff disease begins in infancy. Infants with this disorder typically appear normal until the age of 3 to 6 months, when development slows and muscles used for movement weaken. Affected infants lose motor skills such as turning over, sitting, and crawling. As the disease progresses, infants develop seizures, vision and hearing loss, mental retardation, and paralysis. An eye abnormality called a cherry-red spot, which can be identified with an eye examination, is characteristic of this disorder. Some infants with Sandhoff disease may also have enlarged organs (organomegaly) or bone abnormalities. Children with the severe form of this disorder usually live only into early childhood.
Other forms of Sandhoff disease are very rare. Signs and symptoms can begin in childhood, adolescence, or adulthood and are usually milder than those seen with the infantile form of Sandhoff disease. As in the infantile form, mental abilities and coordination are affected. Characteristic features include muscle weakness, loss of muscle coordination (ataxia) and other problems with movement, speech problems, and mental illness. These signs and symptoms vary widely among people with late-onset forms of Sandhoff disease.
[edit] Causes
Mutations in the HEXB gene cause Sandhoff disease. The HEXB gene provides instructions for making a protein that is part of two critical enzymes in the nervous system. These enzymes, beta-hexosaminidase A and beta-hexosaminidase B, function in nerve cells to break down fatty substances, complex sugars, and molecules that are linked to sugars. In particular, beta-hexosaminidase A breaks down a fatty compound called GM2 ganglioside. Mutations in the HEXB gene disrupt the activity of these enzymes, preventing the breakdown of GM2 ganglioside and other molecules.
As a result, these compounds can accumulate to toxic levels within cells. Progressive damage caused by the buildup of GM2 ganglioside leads to the destruction of nerve cells, which causes the signs and symptoms of Sandhoff disease. The condition is inherited in an autosomal recessive pattern.
[edit] Incidence
Sandhoff disease is a rare disorder; its frequency varies among populations. This condition appears to be more common in the Creole population of northern Argentina; the Metis Indians in Saskatchewan, Canada; and people from Lebanon.
[edit] Diagnosis
Sandhoff disease is determined by doing the following procedures before being detected by a examination, biopsy removing a sample of tissue from the liver, genetic testing, molecular analysis of cells and tissues to determine if it is genetic metabolic disorder, enzyme assay, and sometimes an urinalysis may be done to determine if some of the materials are stored within the body. For a child to obtain this disease and both parents are carriers is only a 25 percent chance their child inherit Sandhoff disease. The parents are given the opportunity to have a DNA mutation done if they are at high risk, so they can determine before they have children.
[edit] Treatment
Sandhoff disease does not attain a specific treatment or cure. However, a person that is suffering from this disease needs to acquire proper nutrition, stay dehydrated, and maintain clearing in the airways. To reduce some symptoms that may occur with Sandhoff disease the patient may be required to take a anticonvulsants to manage seizures, medications to treat respiratory infections in infants usually dying by the age of 3 due to respiratory infections itself, and obtain a precise diet consisting of puree foods due to difficulties swallowing.
Recent work done at Burham Institute for Medical Research and scheduled to be published in Nature, indicates that human embryonic stem cells may provide a potential therapy for the disease.
[edit] See also
[edit] References
Madison foundation-[1] NINDS Sandhoff disease-[2] Related Diseases What is Sandhoff disease-[3]
[edit] External links
This article incorporates public domain text from The U.S. National Library of Medicine
